Mounjaro is available in the UK, prescribed for adults with type 2 diabetes who require improved glycemic control. The drug is administered via injection.
What is Mounjaro and how does it work?
Mounjaro contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by stimulating insulin release, decreasing glucagon secretion, and slowing gastric emptying, all of which help to lower blood glucose levels [1].
Who is prescribing Mounjaro in the UK?
In the UK, Mounjaro is prescribed by healthcare professionals, typically endocrinologists or specialist diabetes teams, for individuals with type 2 diabetes who have not achieved adequate control with other treatments.
How is Mounjaro administered and what are the dosages?
Mounjaro is administered as a once-weekly subcutaneous injection. The starting dose is typically 2.5 mg, with dosages increasing every four weeks as tolerated to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or the maximum dose of 15 mg [1].
What is the clinical evidence supporting Mounjaro's use?
Clinical trials, such as the SURMOUNT program, have demonstrated Mounjaro's efficacy in improving glycemic control and promoting weight loss in adults with type 2 diabetes. These studies have shown significant reductions in HbA1c levels and body weight compared to placebo and other diabetes medications [1].
What are the potential side effects of Mounjaro?
Common side effects of Mounjaro include gastrointestinal issues such as nausea, vomiting, diarrhea, decreased appetite, and abdominal pain. More serious, though less common, side effects can include pancreatitis, gallbladder problems, and diabetic retinopathy complications [1].
When might Mounjaro become available for weight management in the UK?
While Mounjaro is approved for type 2 diabetes in the UK, its use for chronic weight management in individuals without diabetes is currently under review and not yet widely available through the NHS for this indication. Regulatory decisions and further clinical data will influence its availability for weight loss [2].
Are there any patent considerations for Mounjaro in the UK?
Patents play a role in the exclusivity of branded medications like Mounjaro. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate when generic versions might become available [3]. Specific patent expiry dates for Mounjaro in the UK would be detailed on such resources.